Dimri G P, Campisi J
Department of Cell and Molecular Biology, Lawrence Berkeley Laboratory, University of California, Berkeley 94720.
Exp Cell Res. 1994 May;212(1):132-40. doi: 10.1006/excr.1994.1127.
Normal eukaryotic cells divide a limited number of times, after which they enter a state of irreversible growth arrest and altered function termed senescence. Cell senescence entails changes in the expression of growth- and differentiation-specific genes, suggesting that senescent cells express an altered profile of transcription factors. Nuclear extracts were prepared from presenescent (quiescent and growing) and senescent human fibroblasts (WI-38) and from SV40-immortalized WI-38 cells and Y79 human retinoblastoma tumor cells--both of which have escaped senescence. The extracts were assayed for ability to form specific protein-DNA complexes with oligonucleotides containing binding sites for the general transcription factors CTF (CAAT-binding transcription factor), SP1 (promotor-specific transcription factor-1), and TFIID (transcription factor-IID) and the more gene-specific factors AP1 (activator protein factor-1), CREBP (cAMP response element-binding protein), GREBP (glucocorticoid response element-binding protein), NF-kappa B (nuclear factor kappa B) and OctBP (octamer-binding protein). Two TFIID complexes and the GREBP, NF-kappa B, and SP1 complexes were similar in presenescent and senescent cells. AP1, CREBP, and CTF complexes were reduced in senescent cells. Two activities were more abundant in senescent cells: OctBP and one TFIID complex. This TFIID complex was present in quiescent cells, but absent from four human cell lines that lack a functional retinoblastoma protein (pRb); both pRb-specific and TFIID-specific antibodies selectively disrupted it. The data suggest that an altered profile of transcription factors may specify the senescent phenotype and that pRb may interact with TFIID or a TFIID-associated protein(s).
正常真核细胞只能分裂有限次数,之后它们进入一种不可逆的生长停滞状态,并改变功能,即衰老。细胞衰老需要生长和分化特异性基因的表达发生变化,这表明衰老细胞表达的转录因子谱发生了改变。从衰老前(静止和生长)和衰老的人成纤维细胞(WI-38)以及SV40永生化的WI-38细胞和Y79人视网膜母细胞瘤肿瘤细胞(这两种细胞都已逃脱衰老)中制备核提取物。用含有通用转录因子CTF(CAAT结合转录因子)、SP1(启动子特异性转录因子-1)和TFIID(转录因子IID)以及基因特异性更强的因子AP1(激活蛋白因子-1)、CREBP(cAMP反应元件结合蛋白)、GREBP(糖皮质激素反应元件结合蛋白)、NF-κB(核因子κB)和OctBP(八聚体结合蛋白)结合位点的寡核苷酸,检测提取物形成特异性蛋白质-DNA复合物的能力。在衰老前和衰老细胞中,两种TFIID复合物以及GREBP、NF-κB和SP1复合物相似。衰老细胞中AP1、CREBP和CTF复合物减少。衰老细胞中有两种活性更丰富:OctBP和一种TFIID复合物。这种TFIID复合物存在于静止细胞中,但在四种缺乏功能性视网膜母细胞瘤蛋白(pRb)的人细胞系中不存在;pRb特异性抗体和TFIID特异性抗体都能选择性地破坏它。数据表明,转录因子谱的改变可能决定衰老表型,并且pRb可能与TFIID或一种TFIID相关蛋白相互作用。